These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 460695)

  • 1. Topographical distribution of substance P in the cat substantia nigra.
    Gauchy C; Beaujouan JC; Besson MJ; Kerdelhue B; Glowinski J; Michelot R
    Neurosci Lett; 1979 Apr; 12(1):127-31. PubMed ID: 460695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topographical organization of efferent projections from the cat substantia nigra pars reticulata.
    Kemel ML; Desban M; Gauchy C; Glowinski J; Besson MJ
    Brain Res; 1988 Jul; 455(2):307-23. PubMed ID: 2456843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the substance P- and dynorphin-containing projections to the substantia nigra: a radioimmunocytochemical and biochemical study.
    McLean S; Bannon MJ; Zamir N; Pert CB
    Brain Res; 1985 Dec; 361(1-2):185-92. PubMed ID: 2417661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
    Jessell TM; Emson PC; Paxinos G; Cuello AC
    Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P appears reduced in Huntington's disease: immunocytochemical findings in substantia nigra and substantia gelatinosa.
    Vacca LL
    J Submicrosc Cytol; 1983 Apr; 15(2):569-82. PubMed ID: 6190005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct strio-nigral substance P pathways in the rat: an experimental immunohistochemical study.
    Kohno J; Shiosaka S; Shinoda K; Inagaki S; Tohyama M
    Brain Res; 1984 Aug; 308(2):309-17. PubMed ID: 6206922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topographical study of the distribution of gamma-aminobutyric acid (GABA) in the human substantia nigra. A case study.
    Kanazawa I; Toyokura Y
    Brain Res; 1975 Dec; 100(2):371-81. PubMed ID: 1192182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.
    Buck SH; Burks TF; Brown MR; Yamamura HI
    Brain Res; 1981 Mar; 209(2):464-9. PubMed ID: 6164436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional distribution of substance P in the brain of the rat.
    Brownstein MJ; Mroz EA; Kizer JS; Palkovits M; Leeman SE
    Brain Res; 1976 Nov; 116(2):299-305. PubMed ID: 974776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo release of substance P in the cat substantia nigra.
    Michelot R; Leviel V; Torrens Y; Glowinski J; Chéramy A
    Neurosci Lett; 1979 Dec; 15(2-3):141-6. PubMed ID: 93729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental profiles of substance P and GABA contents in the substantia nigra of rat.
    Kanazawa I; Tatsumi S; Nagano H; Muramoto O
    Neurosci Lett; 1982 Dec; 34(2):149-52. PubMed ID: 6191252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains.
    Taquet H; Javoy-Agid F; Cesselin F; Hamon M; Legrand JC; Agid Y
    Brain Res; 1982 Mar; 235(2):303-14. PubMed ID: 7188329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative imaging of substance P in the human brain using a brain mapping analyzer.
    Sutoo D; Yabe K; Akiyama K
    Neurosci Res; 1999 Dec; 35(4):339-46. PubMed ID: 10617325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The substantia nigra of the rat: a Golgi study.
    Juraska JM; Wilson CJ; Groves PM
    J Comp Neurol; 1977 Apr; 172(4):585-600. PubMed ID: 65369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of substance P injected into the substantia nigra.
    James TA; Starr MS
    Br J Pharmacol; 1979 Mar; 65(3):423-9. PubMed ID: 427315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor afferents from the cerebellum, zona incerta and substantia nigra to the mediodorsal thalamic nucleus in the rat.
    Çavdar S; Özgür M; Uysal SP; Amuk ÖC
    J Integr Neurosci; 2014 Dec; 13(4):565-78. PubMed ID: 25164360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct projections from the substantia nigra to the posterior thalamic regions in the cat.
    Takada M; Itoh K; Yasui Y; Sugimoto T; Mizuno N
    Brain Res; 1984 Aug; 309(1):143-6. PubMed ID: 6207889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin in projection neurons of the striatum and nucleus accumbens, with reference to coexistence with enkephalin and GABA: an immunohistochemical study in the cat.
    Sugimoto T; Mizuno N
    J Comp Neurol; 1987 Mar; 257(3):383-95. PubMed ID: 2435769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat.
    Savasta M; Dubois A; Benavides J; Scatton B
    Neurosci Lett; 1986 Dec; 72(3):265-71. PubMed ID: 2950341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some neuroactive compounds in the substantia nigra.
    Krnjević K
    Adv Neurol; 1974; 5():145-52. PubMed ID: 4155230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.